scholarly journals Clinical control study of traditional Chinese medicine hot compress combined with traction in the treatment of cervical spondylotic radiculopathy

Medicine ◽  
2021 ◽  
Vol 100 (4) ◽  
pp. e23880
Author(s):  
Xing Ding ◽  
Jinze Wu ◽  
Qixing Shen ◽  
Jinhai Xu ◽  
Wen Mo
2021 ◽  
Author(s):  
Yuxin Liu ◽  
◽  
Shuangqing Zhai ◽  
Xiuchao Liu ◽  
Jintao Liu

Review question / Objective: P: Patients diagnosed with cervical spondylotic radiculopathy (CSR). I: The treatmen group will be treated with traditional Chinese medicine therapies (with/without additional treatment) including acupuncture of several types (acupuncture, acupoint sticking, acupoint injection, electroacupuncture and so on), massage, cervical traction, fire needle, traditional Chinese medicine hot compress, or their combination. No restrictions are imposed on length of the treatment period, times of treatment, and frequency of treatment. C: The traditional Chinese medicine therapies (with/without additional treatment) including acupuncture of several types (acupuncture, acupoint sticking, acupoint injection, electroacupuncture and so on), massage, cervical traction, fire needle, traditional Chinese medicine hot compress, or their combination will be included in this review. S: Only randomized controlled trials (RCTs) will be included.


2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Cheng Jiang ◽  
Jie Shen ◽  
Dan Shou ◽  
Nani Wang ◽  
Jing Jing ◽  
...  

Abstract The adverse drug reaction (ADR) of traditional Chinese medicine injection (TCMI) has become one of the major concerns of public health in China. There are significant advantages for developing methods to improve the use of TCMI in routine clinical practice. The method of predicting TCMI-induced ADR was illustrated using a nested case-control study in 123 cases and 123 controls. The partial least squares regression (PLSR) models, which mapped the influence of basic characteristics and routine examinations to ADR, were established to predict the risk of ADR. The software was devised to provide an easy-to-use tool for clinic application. The effectiveness of the method was evaluated through its application to new patients with 95.7% accuracy of cases and 91.3% accuracy of controls. By using the method, the patients at high-risk could be conveniently, efficiently and economically recognized without any extra financial burden for additional examination. This study provides a novel insight into individualized management of the patients who will use TCMI.


2006 ◽  
Vol 34 (01) ◽  
pp. 13-21 ◽  
Author(s):  
P. M. K. Poon ◽  
C. K. Wong ◽  
K. P. Fung ◽  
C. Y. S. Fong ◽  
E. L. Y. Wong ◽  
...  

Traditional Chinese medicine (TCM) has been used for prevention and treatment of severe acute respiratory syndrome (SARS) in Hong Kong during the outbreak in spring 2003. We investigated the immunomodulating effects of an innovative TCM regimen derived from two herbal formulas (Sang Ju Yin and Yu Ping Feng San) for treating febrile diseases. Thirty-seven healthy volunteers were given the oral TCM regimen daily for 14 days. Peripheral venous blood samples were taken on days 0, 15 and 29 for hematology, biochemistry and immunology tests, including the measurement of blood lymphocyte subsets and plasma T-helper lymphocyte types 1 and 2 cytokines and receptor. After 3 months, 23 of the volunteers participated in a control study without TCM treatment for the same time course of blood tests. Two volunteers withdrew on day 2, due to headache and dizziness. All others remained well without any side effects. No participants showed significant changes in their blood test results, except that the T-lymphocyte CD4/CD8 ratio increased significantly from 1.31 ± 0.50 ( mean ± SD ) on day 0 to 1.41 ± 0.63 on day 15 ( p < 0.02), and reduced to 1.32 ± 0.47 on day 29 ( p < 0.05). In the control study, there were no changes in the CD4/CD8 ratio. The transient increase in CD4/CD8 ratio was likely due to the TCM intake. We postulate that the administration of the innovative TCM may have beneficial immunomodulatory effects for preventing viral infections including SARS.


2020 ◽  
Vol 2020 ◽  
pp. 1-11
Author(s):  
Yueh-Hsiang Liao ◽  
Jaung-Geng Lin ◽  
Cheng-Chieh Lin ◽  
Chin-Chuan Tsai ◽  
Hui-Lien Lai ◽  
...  

Background. Traditional Chinese medicine (TCM) for the treatment of female infertility remains ambiguous. The aim of the present case-control study was to examine the association between TCM treatment and successful pregnancy among infertile women. Methods. This population-based case-control study included the data from 2,627 infertile women with successful pregnancy and 2,627 infertile women without successful pregnancy using datasets from the Longitudinal Health Insurance Database 2000 of the National Health Insurance Research Database during 2000–2010. The odds ratios (ORs) and 95% confidence intervals (CIs) for the relationship between TCM use and successful pregnancy in infertility women were estimated using logistic regression. Results. Patients who received TCM treatment significantly increased in successful pregnancy (OR = 1.48; 95% CI = 1.31–1.66), compared with patients without TCM. Si-Wu-Tang (OR = 4.25; 95% CI = 2.18, 8.30), Gui-Zhi-Fu-Ling-Wan (OR = 3.27; 95% CI = 2.13, 5.02), and Jia-Wei-Xiao-Yao-San (OR = 3.17; 95% CI = 2.35, 4.28) were the TCM agents that were most strongly associated with successful pregnancy among infertile women. Conclusions. Our study findings indicate that TCM is associated with higher likelihood of successful pregnancy in infertile women, which is worthy of further investigation by randomized control trial.


2020 ◽  
Author(s):  
Yun-Tzu Liang ◽  
Chia-Yang Lin ◽  
Yu-Hsun Wang ◽  
Hsi-Hsien Chou ◽  
James Cheng-Chung Wei

Abstract Background Patients who have Parkinson’s disease (PD) comorbid with dementia is common. With the prolonged life expectancy, dementia is gradually becoming prevalent and affects most patients’ life qualities. However, the efficacy of current treatments in dementia of Parkinson’s disease is limited. Previous studies indicated the potential roles of Traditional Chinese Medicine (TCM) in treating dementia, yet its effects in preventing dementia from Parkinson’s patients are unknown.Methods This case–control study was nested within a national health insurance database of patients over 50 years old with newly diagnosed Parkinson’s disease from year 2000 to 2010. Among these PD patients, dementia and non-dementia groups were discussed respectively in terms of the duration of taking TCM (≥ 90 days versus < 90 days), age (50–64 versus ≥ 65) and gender.Results The risk of dementia in patients with Parkinson's disease is decreased by using TCM for < 90 days and ≥ 90 days, especially in the group who took TCM for more than 90 days. The use of TCM significantly reduces the risk of dementia in the subgroups of age ≥ 65 years, female patients using TCM for both < 90 days and ≥ 90 days, and male patients using TCM for < 90 days. Overall, we can see the protection tendency among all of the target population under TCM use.Conclusions The results showed that there is a significant reduction of nearly 38% in the risk of dementia for patients with Parkinson’s disease after the usage of Traditional Chinese Medicine. The beneficial effects for using TCM ≥ 90 days in women age ≥ 65 years are most prominent.Trial registration The study data were acquired from the Taiwan’s National Health Insurance (NHI) Research Database. The NHI-claimed data provide clinical information for population-based epidemiologic research. This study was approved by the Institutional Review Board of Chung Shan Medical University Hospital.


Sign in / Sign up

Export Citation Format

Share Document